Publication date: Jun 27, 2025
Two authors reported having financial relationships with pharmaceutical companies such as Pfizer and MSD. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
| Concepts | Keywords |
|---|---|
| Drugs | Care |
| Hospitalization | Clinical |
| Innovation | Covid |
| Vaccine | Day |
| Hospitalized | |
| Hr | |
| Invasive | |
| Molnupiravir | |
| Mortality | |
| Nirmatrelvir | |
| Outcomes | |
| Received | |
| Ritonavir | |
| Usual | |
| Ventilation |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |
| drug | DRUGBANK | Ritonavir |
| disease | MESH | death |
| pathway | REACTOME | SARS-CoV-2 Infection |
| drug | DRUGBANK | Aspartame |
| disease | MESH | Infectious Diseases |
| disease | IDO | process |
Original Article
(Visited 2 times, 1 visits today)